Can Gemcitabine Injection 200 Gemchem be used to treat cancer?
Gemzar (Gemcitabine Injection 200 Gemchem) is a chemotherapeutic medicine that is used to treat malignant tumors such as ovarian cancer, lung cancer, pancreatic cancer, and breast cancer in some circumstances.
What are the Gemchem Injection side effects?
- For people receiving Gemcitabine Injection 200 Gemchem, the following adverse effects are common (occurring in more than 30% of cases):
- Features by stopping tumor cells from growing and spreading.
- There’s a fever going around (within 6-12 hours of the first dose)
- nauseous (mild)
- Appetite problems.
- A rash on the skin.
- Blood counts are low.
If you are looking for more detail Read more
What is Gemchem Injection success rate?
For patients with unresectable locally advanced or metastatic pancreatic cancer, gemcitabine therapy has been the conventional first-line treatment since 1997. The 5-year survival rate for patients with metastatic disease is only 2%,1 while 1-year survival rates of 17 to 23% have been recorded with gemcitabine.
How long do you think you’ll be able to stay on gemcitabine?
A 21-day gemcitabine cycle (dose) with paclitaxel. Gemcitabine is taken on days one and eight of the cycle. The period between each treatment cycle allows your body to heal.
Is Gemcitabine Injection 200 causing you to lose your hair?
versus Hair loss using gemcitabine is normally slight, yet, some folks lose more locks than others. When the treatment is over, hair growth should restart. v Nausea and vomiting are prevalent, but they are less common now than they were in the past because to better anti-nausea drugs.
Is Gemcitabine Injection 200 considered a prodrug?
Gemcitabine is a cytidine analog in which two fluorine atoms replace the hydroxyl on the ribose. Gemcitabine is a prodrug that is transformed into active metabolites that inhibit tumor growth and cause apoptosis in malignant cells by swapping nucleic acid building blocks. DNA elongation.
Gemcitabine Injection 200 is used to treat a variety of malignancies.
Gemcitabine, a pyrimidine nucleoside antimetabolite, is one of the most promising new cytotoxic drugs. The drug has been approved to treat non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer, as well as a variety of other solid tumors.
We are a global wholesaler and exporter from India and operate in more than 5 countries like the United Arab Emirates, the United States of America, Italy, Germany, Brazil, etc. Click on our products. if you’re seeking a different product or brand.